Hamner, UNC launch Institute for Drug Safety Sciences - Baltimore Business Journal:

bentlyoupapa1810.blogspot.com
Liver toxicity is a main reasonm for regulatory agencies to deny approvall for new drugs or take action againsyexisting drugs. The researchers, who are working at the newly formede Institute for Drug Safety will use a virtual model of a liver to test how differenr drugs may affectthe organ. The research has the potentiap to speed up the drug development andtesting process. The Institute for Drug Safety Sciences, which opened last week and featuresa 14,000-square-foot researcjh laboratory, will work to study globa drug safety issues. It is being led by Paul the Verne S. Caviness distinguished professor of medicine at UNC.
Watkins, along with his scientist will work with members of the biomedical and pharmaceutical the U.S. Food and Drug Administration and the National Institutee of Health to develop new drugsafety initiatives. The Instituts for Drug Safety Sciences was born from an agreement signeed in April 2008 between UNC and Hamner to collaboratre on research intodrug safety, drug development and publicc health. It is located on Hamner’ s campus in Research Triangle Park.